◆ NeutralMLTX
MoonLake Immunotherapeutics' CFO Sells 39K Shares
The Motley Fool·
MoonLake Immunotherapeutics CFO Matthias Bodenstedt sold 39,120 shares worth approximately $862,000 on June 22 through a pre-planned 10b5-1 trading plan. The sale represented 3.4% of his direct holdings, leaving him with over 1.1 million shares. While the transaction shouldn't concern investors due to its pre-planned nature, the clinical-stage biotech company remains highly volatile with no approved products or revenue.
Read Full Article at The Motley Fool →